Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 12 Best Genomics Stocks to Invest In. Cathie Wood’s ARK Investment acquired 755,000 shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ...

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.

The idea of a think tank is not new. Traditionally found in politics, economics, or science, think tanks bring together experts to study complex problems and propose solutions. In architecture, their ...

WASHINGTON—President Trump is taking more aspirin than his doctors recommend. He briefly tried wearing compression socks for his swelling ankles, but stopped because he didn’t like them. And he ...

Recursion Pharmaceuticals' (NASDAQ: RXRX) stock price has seen a dramatic increase, not due to company-specific news or drug announcements, but rather due to actions taken by artificial intelligence ...

CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Bryan Metzger Every time Bryan publishes a story, you’ll get an alert straight to your inbox!

Wright is a neuroscientist at University College London and Georgetown University who advises the Pentagon and is author of Warhead: How the brain shapes war and war shapes the brain Seven-foot-tall ...

A year after President Donald Trump was sworn in for a second term, his approval rating remains at around 45%, according to Morning Consult’s weekly polling—though voters’ views of his handling of ...